David Muus

David Muus studied law at Groningen University. David further completed post-graduate education in IP and IT law at Grotius Academy and has received education in communication protocols, with a focus on mobile- and IP-networks.

Before joining Sisvel in 2015, he acted as IP counsel and patent licensing specialist at the Dutch incumbent telecom operator KPN. At Sisvel, David started out from Turin and London where he ran Sisvel’s LTE patent pool and its successor the Mobile Communication Program (MCP). Since 2019 David works from Sisvel’s Barcelona office at the head Sisvel’s cellular team, where he is responsible for all of Sisvel’s cellular SEP licensing activities. This includes Sisvel’s bilateral licensing and litigation activity under the cellular SEPs Sisvel controls, as well as the management of two recently launched patent pools: the 5G Multimode Program, the next generation of the MCP which now focusses on 5G enabled consumer electronics, and Sisvel’s Cellular-IoT program, focused on licensing IoT devices enabled with the LPWAN standards Narrowband-IoT and LTE-M.

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More